STOK Stoke Therapeutics, Inc. - Common Stock
$33,19
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 3, 2026
52W-Spanne
$18–$40
68% of range
Analystenbewertung
BUY
19 analysts
Kursziel
$47
+42% upside
P/E (TTM)
-276.6
ROE
-2.0%
Nettogewinnmarge
-3.7%
STOK Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$33.19
Marktkapitalisierung
$1.96B
P/E (TTM)
-276.6
EPS (TTM)
$-0.12
Umsatz (TTM)
$184M
Dividendenrendite
—
ROE
-2.0%
Verschuldungsgrad
—
52W-Spanne
$18 – $40
STOK Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$184M
2022-12-31
→
2025-12-31
EPS
$-0.12
2021-12-31
→
2025-12-31
Freier Cashflow
$45M
2019-12-31
→
2025-12-31
Margen
-3.7%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
STOK
Peer-Median
P/E (TTM)
-276.6
27.2
P/S (TTM) (K/V (TTM))
10.6
25.4
P/B (K/B)
5.5
5.1
Price / FCF (Kurs / FCF)
43.5
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
STOK
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-11.2%
—
Net Profit Margin (Nettogewinnmarge)
-3.7%
-473.7%
ROA
-2.0%
-40.2%
ROE
-2.0%
-50.4%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
STOK
Peer-Median
Current Ratio (Liquiditätsgrad)
5.3
9.0
Quick Ratio
1.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
STOK
Peer-Median
Revenue YoY (Umsatz YoY)
404.5%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
145.9%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
STOK
Peer-Median
STOK Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
19 Analysten
- Starker Kauf 8 42,1%
- Kauf 10 52,6%
- Halten 1 5,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
12 Analysten · 2026-08-15
Median
$46.00
← Unter allen Zielen
$33.19
Tief
$35.00
Hoch
$60.00
Median-Ziel
$46.00
+38,6%
Mittelwert-Ziel
$47.00
+41,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.36%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.93 | $-0.81 | -0.12% |
| 31. März 2026 | $-0.79 | $-0.84 | 0.05% |
| 31. Dezember 2025 | $-0.97 | $-0.73 | -0.24% |
| 30. September 2025 | $-0.65 | $-0.58 | -0.07% |
| 30. Juni 2025 | $-0.40 | $-0.52 | 0.12% |
| 31. März 2025 | $1.98 | $-0.43 | 2.4% |
| 31. Dezember 2024 | $-0.18 | $-0.54 | 0.36% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| GENB | — | — | — | — | — | — |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $184M | $37M | $9M | $12M | |
| R&D Expense | $138M | $89M | $82M | $78M | |
| SG&A Expense | $67M | $49M | $41M | $39M | |
| Operating Expenses | $205M | $138M | $124M | $117M | |
| Operating Income | $-21M | $-101M | $-115M | $-104M | |
| Interest Expense | $9.0K | $26.0K | $49.0K | · | |
| Interest Income | $14M | $13M | $10M | · | |
| Other Non-op | $-51.0K | $-247.0K | $166.0K | $167.0K | |
| Income Tax | $0 | · | · | · | |
| Net Income | $-7M | $-89M | $-105M | $-101M | |
| EPS (Basic) | $-0.12 | $-1.65 | $-2.38 | $-2.60 | |
| EPS (Diluted) | $-0.12 | $-1.65 | $-2.38 | $-2.60 | |
| Shares (Basic) | 59,219,184 | 54,008,883 | 43,994,862 | 38,897,442 | |
| Shares (Diluted) | 59,219,184 | 54,008,883 | 43,994,862 | 38,897,442 | |
| EBITDA | $-21M | $-101M | $-115M | $-104M |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $84M | $128M | $191M | $114M | |
| Receivables | $6M | $2M | · | · | |
| Prepaid Expense | $9M | $11M | $11M | $11M | |
| Other Current Assets | $4M | $2M | $3M | $3M | |
| Current Assets | $306M | $233M | $215M | $244M | |
| PP&E (Net) | $3M | $4M | $6M | $7M | |
| PP&E (Gross) | $13M | $13M | $12M | $11M | |
| Accum. Depreciation | $10M | $9M | $7M | $4M | |
| Total Assets | $418M | $272M | $228M | $256M | |
| Accounts Payable | $5M | $2M | $2M | $766.0K | |
| Current Liabilities | $58M | $40M | $31M | $31M | |
| Capital Leases | $1M | $2M | $5M | $3M | |
| Other Non-current Liabilities | $1M | $2M | $5M | $3M | |
| Total Liabilities | $66M | $43M | $69M | $71M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $4.0K | |
| Paid-in Capital | $850M | $720M | $561M | $483M | |
| Retained Earnings | $-498M | $-491M | $-402M | $-297M | |
| AOCI | $543.0K | $-151.0K | $-24.0K | $-1M | |
| Stockholders' Equity | $352M | $229M | $160M | $185M | |
| Liabilities + Equity | $418M | $272M | $228M | $256M | |
| Shares Outstanding | 58,921,999 | 54,032,826 | 45,918,233 | 39,439,575 |
Cashflow 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $32M | $27M | $25M | $23M | |
| Operating Cash Flow | $46M | $-87M | $-81M | $-32M | |
| CapEx | $670.0K | $203.0K | $2M | $4M | |
| Investing Cash Flow | $-187M | $-107M | $106M | $-46M | |
| Financing Cash Flow | $97M | $131M | $53M | $46M | |
| Net Change in Cash | $-44M | $-63M | $78M | $-31M | |
| Taxes Paid | $573.0K | · | · | · | |
| Free Cash Flow | $45M | $-87M | $-83M | $-36M |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -11.2% | -277.3% | -1307.2% | -841.2% | |
| Net Margin | -3.7% | -243.4% | -1192.5% | -814.7% | |
| EBITDA Margin | -11.2% | -277.3% | -1307.2% | -841.2% | |
| ROA | -2.0% | -35.6% | -43.2% | -40.8% | |
| ROE | -2.0% | -38.6% | -63.0% | -52.0% |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 5.3 | 5.8 | 7.0 | 7.8 | |
| Quick Ratio | 1.6 | 3.2 | 6.2 | 3.6 | |
| Interest Coverage | -2287.8 | -3898.9 | · | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.1 | 0.0 | 0.1 | |
| Receivables Turnover | 48.5 | · | · | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 404.5% | 316.3% | -29.2% | · | |
| Revenue CAGR 3Y | 145.9% | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $184M | $37M | $9M | $12M | |
| Net Income TTM | $-7M | $-89M | $-105M | $-101M | |
| Market Cap | $1.87B | $596M | $242M | $364M | |
| P/E | -264.5 | -6.7 | -2.2 | -3.5 | |
| P/S | 10.1 | 16.3 | 27.5 | 29.3 | |
| P/B | 5.3 | 2.6 | 1.5 | 2.0 | |
| P / Tangible Book | 5.3 | 2.6 | 1.5 | 2.0 | |
| P / Cash Flow | 41.0 | -6.9 | -3.0 | -11.4 | |
| P / FCF | 41.6 | -6.8 | -2.9 | -10.2 | |
| Earnings Yield | -0.38% | -15.0% | -45.2% | -28.2% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $6M | $1M | $11M | $14M | $159M | $23M | $5M | $5M | $4M | $3M | $3M | $-2M | $5M | $3M | $3M | |
| R&D Expense | $50M | $40M | $42M | $38M | $26M | $33M | $23M | $22M | $21M | $22M | $22M | $20M | $21M | $20M | $21M | $20M | |
| SG&A Expense | $25M | $20M | $21M | $16M | $15M | $15M | $13M | $13M | $13M | $10M | $11M | $10M | $10M | $10M | $9M | $10M | |
| Operating Expenses | $75M | $60M | $63M | $54M | $41M | $47M | $36M | $35M | $34M | $33M | $32M | $31M | $31M | $30M | $30M | $30M | |
| Operating Income | $-65M | $-53M | $-61M | $-43M | $-27M | $111M | $-14M | $-30M | $-29M | $-28M | $-30M | $-27M | $-33M | $-25M | $-27M | $-27M | |
| Interest Expense | $17.0K | $23.0K | $2.0K | $3.0K | $3.0K | $1.0K | $-1.0K | $0 | $5.0K | $22.0K | · | · | · | · | · | · | |
| Interest Income | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $4M | $4M | $2M | · | · | · | · | · | · | |
| Other Non-op | $308.0K | $18.0K | $-110.0K | $3.0K | $28.0K | $28.0K | $201.0K | $28.0K | $-48.0K | $-428.0K | $42.0K | $41.0K | $41.0K | $42.0K | $41.0K | $42.0K | |
| Pretax Income | $-62M | $-50M | · | $-40M | $-23M | $114M | · | $-26M | $-26M | $-26M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $-1M | $0 | $1M | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income | $-62M | $-50M | $-58M | $-38M | $-23M | $113M | $-10M | $-26M | $-26M | $-26M | $-27M | $-25M | $-31M | $-23M | $-26M | $-26M | |
| EPS (Basic) | $-0.93 | $-0.79 | $-1.02 | $-0.65 | $-0.40 | $1.95 | $-0.15 | $-0.47 | $-0.46 | $-0.57 | $-0.61 | $-0.55 | $-0.69 | $-0.53 | $-0.65 | $-0.66 | |
| EPS (Diluted) | $-0.93 | $-0.79 | $-0.97 | $-0.65 | $-0.40 | $1.90 | $-0.15 | $-0.47 | $-0.46 | $-0.57 | $-0.61 | $-0.55 | $-0.69 | $-0.53 | $-0.65 | $-0.66 | |
| Shares (Basic) | 66,017,895 | 63,063,507 | -115,609,022 | 58,611,677 | 58,353,855 | 57,862,674 | -104,345,028 | 56,341,074 | 55,765,948 | 46,246,889 | -86,996,093 | 44,266,017 | 44,188,464 | 42,536,474 | -77,229,527 | 39,420,310 | |
| Shares (Diluted) | 66,017,895 | 63,063,507 | -117,144,948 | 58,611,677 | 58,353,855 | 59,398,600 | -104,345,028 | 56,341,074 | 55,765,948 | 46,246,889 | -86,996,093 | 44,266,017 | 44,188,464 | 42,536,474 | -77,229,527 | 39,420,310 | |
| EBITDA | $-65M | $-53M | · | $-43M | $-27M | $111M | · | $-30M | $-29M | $-28M | · | $-27M | $-33M | $-25M | · | $-27M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $156M | $84M | $83M | $101M | $275M | $128M | $150M | $193M | $179M | $191M | $190M | $192M | $190M | $114M | $113M | |
| Receivables | $7M | $4M | $6M | $9M | · | · | $2M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $15M | $10M | $9M | $8M | $14M | $13M | $11M | $10M | $10M | $11M | $11M | $11M | $11M | $10M | $11M | $13M | |
| Other Current Assets | $6M | $7M | $4M | $6M | $7M | $5M | $2M | $4M | $4M | $4M | $3M | $4M | $4M | $6M | $3M | · | |
| Current Assets | $323M | $367M | $306M | $272M | $270M | $376M | $233M | $254M | $297M | $193M | $215M | $230M | $246M | $270M | $244M | $265M | |
| PP&E (Net) | $5M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | |
| PP&E (Gross) | · | · | $13M | · | · | · | $13M | · | · | · | $12M | · | · | · | $11M | · | |
| Accum. Depreciation | · | · | $10M | · | · | · | $9M | · | · | · | $7M | · | · | · | $4M | · | |
| Total Assets | $394M | $443M | $418M | $360M | $385M | $407M | $272M | $293M | $308M | $205M | $228M | $240M | $257M | $282M | $256M | $278M | |
| Accounts Payable | $5M | $7M | $5M | $6M | $4M | $2M | $2M | $2M | $4M | $2M | $2M | $3M | $2M | $4M | $766.0K | $2M | |
| Current Liabilities | $42M | $41M | $58M | $42M | $39M | $45M | $40M | $50M | $44M | $36M | $31M | $25M | $22M | $32M | $31M | $29M | |
| Capital Leases | $837.0K | $990.0K | $1M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $5M | $819.0K | $1M | $2M | $3M | $3M | |
| Other Non-current Liabilities | $837.0K | $991.0K | $1M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $5M | $959.0K | $2M | $2M | $3M | $4M | |
| Total Liabilities | $48M | $48M | $66M | $52M | $50M | $57M | $43M | $61M | $65M | $65M | $69M | $67M | $67M | $68M | $71M | $73M | |
| Common Stock | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $955M | $943M | $850M | $747M | $736M | $728M | $720M | $712M | $697M | $569M | $561M | $548M | $541M | $534M | $483M | $477M | |
| Retained Earnings | $-609M | $-548M | $-498M | $-440M | $-401M | $-378M | $-491M | $-480M | $-454M | $-428M | $-402M | $-375M | $-350M | $-320M | $-297M | $-271M | |
| AOCI | $-542.0K | $-115.0K | $543.0K | $446.0K | $96.0K | $-104.0K | $-151.0K | $166.0K | $-15.0K | · | $-24.0K | $-147.0K | $-379.0K | $-598.0K | $-1M | $-2M | |
| Stockholders' Equity | $346M | $395M | $352M | $308M | $335M | $350M | $229M | $232M | $243M | $140M | $160M | $173M | $190M | $214M | $185M | $204M | |
| Liabilities + Equity | $394M | $443M | $418M | $360M | $385M | $407M | $272M | $293M | $308M | $205M | $228M | $240M | $257M | $282M | $256M | $278M | |
| Shares Outstanding | 62,402,595 | 62,240,347 | 58,921,999 | 55,120,002 | 54,723,455 | 54,595,714 | 54,032,826 | 52,941,191 | 52,305,641 | 46,498,077 | 45,918,233 | 44,293,115 | 44,202,997 | 44,175,089 | 39,439,575 | 39,426,440 |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $9M | $10M | $8M | $8M | $7M | $7M | $7M | $7M | $5M | $6M | $7M | $7M | $6M | $6M | $6M | |
| Operating Cash Flow | $-57M | $-61M | $-30M | $-30M | $-25M | $132M | $-23M | $-22M | $-17M | $-25M | $-21M | $-17M | $-22M | $-21M | $-22M | $-22M | |
| CapEx | $2M | $353.0K | $232.0K | $132.0K | $154.0K | $152.0K | $42.0K | $103.0K | $46.0K | $12.0K | $229.0K | $383.0K | $839.0K | $165.0K | $409.0K | $2M | |
| Investing Cash Flow | $9M | $51M | $-61M | $9M | $-148M | $14M | $819.0K | $-30M | $-88M | $10M | $15M | $15M | $23M | $53M | $22M | $67M | |
| Financing Cash Flow | $2M | $84M | $92M | $3M | $554.0K | $1M | $568.0K | $8M | $121M | $2M | $7M | $562.0K | $48.0K | $45M | $43.0K | $434.0K | |
| Net Change in Cash | $-46M | $74M | $826.0K | $-18M | $-173M | $147M | $-22M | $-43M | $15M | $-13M | $1M | $-2M | $2M | $77M | $160.0K | $46M | |
| Free Cash Flow | · | $-61M | · | · | · | $132M | · | · | · | $-25M | · | · | · | $-22M | · | · | |
| Levered FCF | · | $-61M | · | · | · | $132M | · | · | · | · | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -701.6% | -857.6% | · | -405.3% | -197.6% | 70.2% | · | -613.1% | -607.4% | -673.0% | · | -823.3% | 1340.7% | -479.2% | · | -934.5% | |
| Net Margin | -660.8% | -802.8% | · | -360.7% | -170.0% | 71.2% | · | -540.0% | -531.9% | -625.6% | · | -741.9% | 1235.5% | -437.6% | · | -898.8% | |
| Pretax Margin | -660.8% | -802.8% | · | -372.7% | -170.0% | 72.0% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -701.6% | -857.6% | · | -405.3% | -197.6% | 70.2% | · | -613.1% | -607.4% | -673.0% | · | -823.3% | 1340.7% | -479.2% | · | -934.5% | |
| ROA | -15.8% | -11.8% | · | -11.7% | -6.8% | 36.9% | · | -9.9% | -9.1% | -10.8% | · | -9.5% | -11.0% | -7.5% | · | -9.8% | |
| ROE | -18.1% | -13.4% | · | -14.2% | -8.1% | 46.0% | · | -13.1% | -11.9% | -14.9% | · | -13.0% | -14.8% | -9.9% | · | -11.8% | |
| ROIC | -18.9% | -13.5% | · | -13.5% | -8.2% | 31.4% | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.7 | 9.0 | · | 6.5 | 7.0 | 8.4 | · | 5.1 | 6.7 | 5.4 | · | 9.1 | 11.3 | 8.6 | · | 9.2 | |
| Quick Ratio | 2.8 | 3.9 | · | 2.2 | 2.6 | 6.2 | · | 3.0 | 4.3 | 5.0 | · | 7.5 | 8.8 | 6.0 | · | 3.9 | |
| Interest Coverage | -3848.8 | -2322.5 | · | -14363.7 | -9100.0 | 111240.0 | · | · | · | · | · | · | · | · | · | · |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.5 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | -0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.6 | 2.8 | · | 2.3 | · | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $40M | $189M | · | $188M | $182M | $173M | · | $17M | $10M | $10M | · | $9M | $9M | $14M | · | · | |
| Net Income TTM | $-173M | $1M | · | $25M | $37M | $34M | · | $-103M | $-107M | $-104M | · | $-104M | $-104M | $-98M | · | $-98M | |
| Market Cap | $2.04B | $2.03B | · | $1.30B | $621M | $363M | · | $651M | $707M | $628M | · | $175M | $470M | $368M | · | $506M | |
| P/E | -11.8 | 542.7 | · | 61.8 | 19.9 | 16.6 | · | -6.0 | -6.0 | -5.8 | · | -1.6 | -4.2 | -3.4 | · | -5.0 | |
| P/S | 51.0 | 10.7 | · | 6.9 | 3.4 | 2.1 | · | 37.7 | 71.6 | 61.6 | · | 19.6 | 53.4 | 25.8 | · | · | |
| P/B | 5.9 | 5.1 | · | 4.2 | 1.9 | 1.0 | · | 2.8 | 2.9 | 4.5 | · | 1.0 | 2.5 | 1.7 | · | 2.5 | |
| P / Tangible Book | 5.9 | 5.1 | · | 4.2 | 1.9 | 1.0 | · | 2.8 | 2.9 | 4.5 | · | 1.0 | 2.5 | 1.7 | · | 2.5 | |
| P / Cash Flow | · | -33.5 | · | · | · | 2.8 | · | · | · | -25.6 | · | · | · | -17.2 | · | · | |
| P / FCF | · | -33.3 | · | · | · | 2.8 | · | · | · | -25.5 | · | · | · | -17.1 | · | · | |
| Earnings Yield | -8.5% | 0.18% | · | 1.6% | 5.0% | 6.0% | · | -16.7% | -16.8% | -17.3% | · | -61.7% | -23.6% | -29.8% | · | -19.9% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $184M | $37M | $9M | $12M | — |
| Betriebsgewinnmarge % | -11.2% | -277.3% | -1307.2% | -841.2% | — |
| Nettoergebnis | $-7M | $-89M | $-105M | $-101M | $-86M |
| Verwässerte EPS | $-0.12 | $-1.65 | $-2.38 | $-2.60 | $-2.34 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.3 | 5.8 | 7.0 | 7.8 | 13.4 |
| Quick Ratio | 1.6 | 3.2 | 6.2 | 3.6 | 8.5 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $45M | $-87M | $-83M | $-36M | $-68M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 206 Einreicher · $2.0B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 37 (-2 vs. Vorquartal) | 25 (-1 vs. Vorquartal) | 64 (-8 vs. Vorquartal) | 57 (-1 vs. Vorquartal) | +7.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $184.001.738 | 5.623.525 | 9,14% | Aktien |
| FMR LLC | $150.968.444 | 4.613.950 | 7,50% | Aktien |
| Lynx1 Capital Management LP | $132.136.579 | 4.038.404 | 6,56% | Aktien |
| Redmile Group, LLC | $129.110.502 | 3.945.920 | 6,41% | Aktien |
| BAKER BROS. ADVISORS LP | $109.176.726 | 3.336.697 | 5,42% | Aktien |
| TORONTO DOMINION BANK | $103.829.002 | 3.173.258 | 5,16% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $97.499.612 | 2.979.817 | 4,84% | Aktien |
| STATE STREET CORP | $93.325.293 | 2.852.240 | 4,63% | Aktien |
| VANGUARD GROUP INC | $86.966.267 | 2.739.958 | 4,32% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.644.579 | 2.586.937 | 4,20% | Aktien |
| BVF INC/IL | $83.356.065 | 2.547.557 | 4,14% | Aktien |
| Siren, L.L.C. | $65.287.754 | 1.995.347 | 3,24% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $59.664.920 | 1.823.500 | 2,96% | Aktien |
| Skorpios Trust | $53.020.254 | 2.256.181 | 2,63% | Aktien |
| JANUS HENDERSON GROUP PLC | $51.840.980 | 1.593.881 | 2,57% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $43.134.838 | 1.318.037 | 2,14% | Aktien |
| Assenagon Asset Management S.A. | $36.920.855 | 1.128.388 | 1,83% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $31.236.868 | 954.672 | 1,55% | Aktien |
| Polar Capital Holdings Plc | $27.279.188 | 833.716 | 1,35% | Aktien |
| EcoR1 Capital, LLC | $24.049.200 | 735.000 | 1,19% | Aktien |
| MPM BIOIMPACT LLC | $23.666.834 | 723.314 | 1,18% | Aktien |
| Opaleye Management Inc. | $22.904.000 | 700.000 | 1,14% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $18.552.011 | 566.993 | 0,92% | Aktien |
| Troluce Capital Advisors LLC | $16.242.732 | 496.416 | 0,81% | Aktien |
| FIRST TRUST ADVISORS LP | $16.062.673 | 490.913 | 0,80% | Aktien |
| Candriam S.C.A. | $15.694.935 | 480.136 | 0,78% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15.280.633 | 467.012 | 0,76% | Aktien |
| Granahan Investment Management, LLC | $15.103.814 | 461.608 | 0,75% | Aktien |
| Erste Asset Management GmbH | $13.875.261 | 428.381 | 0,69% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $13.169.898 | 402.503 | 0,65% | Aktien |
| GOLDMAN SACHS GROUP INC | $12.775.295 | 390.443 | 0,63% | Aktien |
| Parkman Healthcare Partners LLC | $11.630.095 | 355.443 | 0,58% | Aktien |
| Artisan Partners Limited Partnership | $11.620.606 | 355.153 | 0,58% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $9.816.000 | 300.000 | 0,49% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $8.540.836 | 261.028 | 0,42% | Aktien |
| CITADEL ADVISORS LLC | $7.719.237 | 235.918 | 0,38% | Aktien |
| Birchview Capital, LP | $5.827.759 | 178.110 | 0,29% | Aktien |
| NORGES BANK | $5.339.904 | 163.200 | 0,27% | Aktien |
| BAILLIE GIFFORD & CO | $4.441.216 | 135.734 | 0,22% | Aktien |
| DAFNA Capital Management LLC | $4.282.230 | 130.875 | 0,21% | Aktien |
| ExodusPoint Capital Management, LP | $4.242.475 | 129.660 | 0,21% | Aktien |
| BANK OF AMERICA CORP /DE/ | $4.226.737 | 129.179 | 0,21% | Aktien |
| JANE STREET GROUP, LLC | $3.932.879 | 120.198 | 0,20% | Aktien |
| GILDER GAGNON HOWE & CO LLC | $3.699.487 | 113.065 | 0,18% | Aktien |
| BlackRock, Inc. | $3.657.180 | 111.772 | 0,18% | Aktien |
| Jump Financial, LLC | $3.414.332 | 104.350 | 0,17% | Aktien |
| Schonfeld Strategic Advisors LLC | $3.344.932 | 102.229 | 0,17% | Aktien |
| JPMORGAN CHASE & CO | $2.800.925 | 83.993 | 0,14% | Aktien |
| Palo Alto Investors LP | $2.769.126 | 84.631 | 0,14% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.649.273 | 80.968 | 0,13% | Aktien |
| XTX Topco Ltd | $2.604.937 | 79.613 | 0,13% | Aktien |
| RHUMBLINE ADVISERS | $2.484.451 | 75.931 | 0,12% | Aktien |
| Swiss National Bank | $2.427.824 | 74.200 | 0,12% | Aktien |
| Trexquant Investment LP | $2.404.102 | 73.475 | 0,12% | Aktien |
| TD Asset Management Inc | $2.198.784 | 67.200 | 0,11% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.164.755 | 66.160 | 0,11% | Aktien |
| CITIGROUP INC | $2.164.330 | 66.147 | 0,11% | Aktien |
| Rhenman & Partners Asset Management AB | $2.110.440 | 64.500 | 0,10% | Aktien |
| ALPS ADVISORS INC | $2.061.687 | 63.010 | 0,10% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.040.779 | 62.371 | 0,10% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $2.031.418 | 62.390 | 0,10% | Aktien |
| HighVista Strategies LLC | $2.006.260 | 61.316 | 0,10% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.968.664 | 60.167 | 0,10% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $1.925.343 | 58.843 | 0,10% | Aktien |
| Bank of New York Mellon Corp | $1.903.453 | 58.174 | 0,09% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.680.291 | 51.606 | 0,08% | Aktien |
| Woodline Partners LP | $1.639.926 | 50.120 | 0,08% | Aktien |
| Quantinno Capital Management LP | $1.633.644 | 49.928 | 0,08% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $1.623.272 | 49.611 | 0,08% | Aktien |
| Moran Wealth Management, LLC | $1.569.807 | 47.977 | 0,08% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $1.469.128 | 44.900 | 0,07% | Aktien |
| Rafferty Asset Management, LLC | $1.431.238 | 43.742 | 0,07% | Aktien |
| HUSSMAN STRATEGIC ADVISORS, INC. | $1.374.240 | 42.000 | 0,07% | Aktien |
| Quadrature Capital Ltd | $1.348.882 | 41.225 | 0,07% | Aktien |
| PLATINUM INVESTMENT MANAGEMENT LTD | $1.335.467 | 40.815 | 0,07% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1.164.766 | 35.598 | 0,06% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.093.033 | 33.746 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $1.051.359 | 32.132 | 0,05% | Aktien |
| Corient Private Wealth LP | $1.009.020 | 30.838 | 0,05% | Aktien |
| OMERS ADMINISTRATION Corp | $981.600 | 30.000 | 0,05% | Aktien |
| Squarepoint Ops LLC | $959.023 | 29.310 | 0,05% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $883.833 | 27.012 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $871.628 | 26.639 | 0,04% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $821.730 | 25.114 | 0,04% | Aktien |
| Cresset Asset Management, LLC | $798.728 | 24.411 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $736.200 | 22.500 | 0,04% | Kaufoption |
| PROFUND ADVISORS LLC | $733.452 | 22.416 | 0,04% | Aktien |
| Invesco Ltd. | $719.415 | 21.987 | 0,04% | Aktien |
| D. E. Shaw & Co., Inc. | $698.736 | 21.355 | 0,03% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $687.120 | 21.000 | 0,03% | Verkaufsoption |
| LPL Financial LLC | $675.504 | 20.645 | 0,03% | Aktien |
| AMERIPRISE FINANCIAL INC | $668.240 | 20.423 | 0,03% | Aktien |
| Balyasny Asset Management L.P. | $652.404 | 19.939 | 0,03% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $558.432 | 17.067 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $531.536 | 16.245 | 0,03% | Aktien |
| Aquatic Capital Management LLC | $506.211 | 15.471 | 0,03% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $498.587 | 15.238 | 0,02% | Aktien |
| AlphaQuest LLC | $477.243 | 15.036 | 0,02% | Aktien |
| MORGAN STANLEY | $476.959 | 14.577 | 0,02% | Aktien |
| CIM, LLC | $476.272 | 14.556 | 0,02% | Aktien |
Unternehmensinsider 16 Insider · 7 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ian F Smith | Chief Executive Officer | 17. Februar 2026 A | — | 0 | 0 | $0 |
| Stephen J Tulipano | CFO | 1. Dezember 2023 A | 11.762 | 0 | 0 | $0 |
| Huw M. Nash | COO & CBO | 1. Dezember 2023 A | 0 | 0 | 0 | $0 |
| Jonathan Allan | GENERAL COUNSEL & CORP SEC | 14. August 2026 M | 21.225 | 0 | 3 | $-135.284 |
| Barry Ticho | CHIEF MEDICAL OFFICER | 14. August 2026 M | 25.655 | 0 | 7 | $-652.076 |
| Thomas Mccauley | Chief Scientific Officer | 15. Juli 2026 A | — | 0 | 0 | $0 |
| Gene Liau | EVP Research & Preclinical Dev | 2. März 2021 M | 21.351 | 0 | 0 | $0 |
| Edward M. Kaye MD | Direktor | 14. August 2026 M | 124.557 | 0 | 2 | $-402.562 |
| Seth Loring Harrison | Direktor | 16. Juli 2026 G | 17.161.713 | 0 | 0 | $0 |
| Adrian R. Krainer | Direktor | 3. Juni 2026 A | — | 0 | 0 | $0 |
| Jennifer Burstein | Direktor | 3. Juni 2026 A | — | 0 | 0 | $0 |
| Arthur Tzianabos | Direktor | 3. Juni 2026 A | — | 0 | 0 | $0 |
| Julie Smith | Direktor | 3. Juni 2026 A | — | 0 | 0 | $0 |
| LEVIN ARTHUR A | Direktor | 3. Juni 2026 A | 4.237 | 0 | 1 | $-22.264 |
| Garry E Menzel | Direktor | 13. Juni 2023 A | — | 0 | 0 | $0 |
| Robin A. Walker | — | 7. Juli 2020 S | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Blue Horizon Enterprise Ltd, Ezbon International Ltd, Montrago Trustees Ltd, Skorpios Trust ×3 Einreichungen | 26. August 2025 | 4,10% | Änderung | — | SEC |
| Blue Horizon Enterprise Ltd., Ezbon International Limited, Montrago Trustees Limited, Skorpios Trust ×4 Einreichungen | 27. Dezember 2024 | 13,00% | Änderung | — | SEC |
| ATP Life Science Ventures, L.P., formerly known as Apple Tree Partners IV, L.P., ATP III GP, Ltd., Seth L. Harrison | 29. Juni 2021 | — | Erste Einreichung | — | SEC |
| Apple Tree Partners IV, L.P., ATP III GP, Ltd., Seth L. Harrison ×2 Einreichungen | 27. November 2020 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 50 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| GNOM · Global X Funds | 1,45% | 26.232 NS | 31. Mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,18% | 15.670 NS | 31. Mai 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 1,12% | 58.873 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,75% | 8.521 NS | 30. April 2026 | N-PORT |
| HRTS · Tema ETF Trust | 0,60% | 10.049 NS | 31. Mai 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,56% | 179.037 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,41% | 64.471 NS | 30. April 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,26% | 100.854 NS | 30. April 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,23% | 85.288 NS | 30. April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,14% | 3.388 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,12% | 361.674 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 75.065 SH | 8. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 16.704 NS | 30. April 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 59.041 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,11% | 496.085 SH | 8. August 2026 | Täglich |
| FSMD · FIDELITY COVINGTON TRUST | 0,10% | 72.925 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2.111 NS | 31. Mai 2026 | N-PORT |
| ESSC · Strategy Shares | 0,08% | 623 NS | 30. April 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,07% | 6.327 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,07% | 22.102 NS | 31. Mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 13.588 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,05% | 1.385.028 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,05% | 16.624 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 317.008 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,05% | 21.239 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 179.692 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,04% | 2.305 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 247.558 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 27.702 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,03% | 2.364 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,02% | 1.803 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 18.412 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 643.361 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 111.259 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,02% | 1.824 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.915 SH | 8. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 127.867 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.903 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 46 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.751 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 16.308 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.507 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 80.160 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 13.581 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 28.492 NS | 31. Mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 11.068 NS | 30. April 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 407 NS | 30. April 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 341 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.885.403 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.620 SH | 8. August 2026 | Täglich |